In summary, our results demonstrate that it's possible to find GCSCs with a CD24+CD44+CD54+EpCAM+ phenotype in the peripheral blood of most GC patients, and the level of these cGCSCs is related with local and distant metastasis, as well as overall survival. This evidence concerns the gene CD44 and gastric cancer.